A. Blain

发表

δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches

V. Straub, A. Blain, 2011, Skeletal Muscle.

Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics

H. Lochmüller, R. Manzano, M. Wood, 2015, Scientific Reports.

Steroid treatment causes deterioration of myocardial function in the {delta}-sarcoglycan-deficient mouse model for dilated cardiomyopathy.

G. MacGowan, K. Bushby, V. Straub, 2008, Cardiovascular research.

Beta-Blockers, Left and Right Ventricular Function, and In-Vivo Calcium Influx in Muscular Dystrophy Cardiomyopathy

A. Blamire, G. MacGowan, S. Laval, 2013, PloS one.

Assessment of ventricular function in mouse models of muscular dystrophy: A comparison of MRI with conductance catheter

A. Blamire, G. MacGowan, S. Laval, 2015, Neuromuscular Disorders.

Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy

G. MacGowan, R. Manzano, M. Wood, 2018, PloS one.

Molecular Pathogenesis of Genetic and Inherited Diseases Long-Term Blocking of Calcium Channels in mdx Mice Results in Differential Effects on Heart and Skeletal Muscle

A. Blamire, G. MacGowan, Hanns Lochmüller, 2010 .

Development and Application of an Ultrasensitive Hybridization-Based ELISA Method for the Determination of Peptide-Conjugated Phosphorodiamidate Morpholino Oligonucleotides.

S. Laval, V. Straub, M. Gait, 2015, Nucleic acid therapeutics.

Absence of Cardiac Benefit with Early Combination ACE Inhibitor and Beta Blocker Treatment in mdx Mice

A. Blamire, G. MacGowan, S. Laval, 2015, Journal of Cardiovascular Translational Research.

Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathy

A. Blamire, G. MacGowan, S. Laval, 2013, Journal of Cardiovascular Magnetic Resonance.

Standard Operating Procedures (SOPs) for Evaluating the Heart in Preclinical Studies of Duchenne Muscular Dystrophy

D. Kass, K. Kinnett, D. Duan, 2016, Journal of Cardiovascular Translational Research.

Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness

Kristen M. Laricchia, D. MacArthur, M. Lek, 2020, Genetics in Medicine.

Intolerance to β‐blockade in a mouse model of δ‐sarcoglycan‐deficient muscular dystrophy cardiomyopathy

G. MacGowan, K. Bushby, Hanns Lochmüller, 2010, European journal of heart failure.

Attenuation of adverse cardiac effects in prednisolone-treated δ-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism

Hanns Lochmüller, V. Straub, R. Bauer, 2010, Neuromuscular Disorders.

Contrasting effects of steroids and angiotensin‐converting‐enzyme inhibitors in a mouse model of dystrophin‐deficient cardiomyopathy

G. MacGowan, K. Bushby, V. Straub, 2009, European journal of heart failure.

OD11 The MYO-SEQ project: application of exome sequencing technologies to 1000 patients affected by limb-girdle weakness of unknown origin

M. Lek, D. Macarthur, H. Lochmüller, 2017, Neuromuscular Disorders.

Attenuation of adverse cardiac effects in prednisolone-treated delta-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism. Neuromuscul Disord

G. MacGowan, K. Bushby, Hanns Lochmüller, 2009 .

G.P.217 Identification of novel therapy-responsive protein biomarkers for Duchenne muscular dystrophy by aptamer-based serum proteomics

H. Lochmüller, R. Manzano, T. Roberts, 2015, Neuromuscular Disorders.

Steroid treatment causes deterioration of myocardial function in the {delta}-sarcoglycan-deficient mouse model for dilated cardiomyopathy.

A. Blain, Volker Straub, Guy A. MacGowan, 2008, Cardiovascular research.